Laterza, Lucrezia
 Distribuzione geografica
Continente #
EU - Europa 1.724
NA - Nord America 1.481
AS - Asia 588
AF - Africa 7
OC - Oceania 6
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.813
Nazione #
US - Stati Uniti d'America 1.465
DE - Germania 458
IT - Italia 361
SE - Svezia 289
SG - Singapore 225
CN - Cina 194
PL - Polonia 162
UA - Ucraina 99
IE - Irlanda 90
FR - Francia 87
ID - Indonesia 72
GB - Regno Unito 54
FI - Finlandia 35
RU - Federazione Russa 30
IN - India 29
BE - Belgio 17
TR - Turchia 14
CA - Canada 12
IR - Iran 10
NL - Olanda 10
JP - Giappone 9
KR - Corea 9
CZ - Repubblica Ceca 7
IQ - Iraq 7
RO - Romania 7
CI - Costa d'Avorio 6
PH - Filippine 6
AU - Australia 5
ES - Italia 5
HK - Hong Kong 4
LT - Lituania 4
BR - Brasile 3
EU - Europa 3
MX - Messico 3
CH - Svizzera 2
MD - Moldavia 2
PK - Pakistan 2
PT - Portogallo 2
BN - Brunei Darussalam 1
CY - Cipro 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
PE - Perù 1
PR - Porto Rico 1
SA - Arabia Saudita 1
TH - Thailandia 1
VN - Vietnam 1
Totale 3.813
Città #
Chandler 336
Singapore 181
Ashburn 149
Warsaw 144
Dublin 87
Jakarta 70
Ann Arbor 68
New York 67
Jacksonville 66
San Mateo 62
Rome 60
Cattolica 54
Milan 52
Wilmington 39
Nanjing 34
Boston 33
Woodbridge 30
Moscow 28
Dearborn 27
Boardman 26
Beijing 25
Fairfield 25
Marseille 25
Nürnberg 24
Munich 23
Lawrence 22
Princeton 18
Houston 17
Los Angeles 17
Seattle 17
Kraków 15
Brussels 14
Redwood City 14
Bremen 13
Lancaster 13
Helsinki 12
Izmir 12
Monza 11
Mountain View 11
Shenyang 11
Fremont 10
Naples 10
Hangzhou 9
Hebei 9
Nanchang 9
Seoul 9
Tianjin 9
Kish 8
London 8
Paris 8
Cambridge 7
Shanghai 7
Abidjan 6
Andover 6
Changsha 6
Jiaxing 6
Redmond 6
San Diego 6
Toronto 6
Washington 6
Groningen 5
Kunming 5
Pune 5
Amsterdam 4
Arezzo 4
Augusta 4
Baghdad 4
Brno 4
Busto Arsizio 4
Cagayan de Oro 4
Frankfurt am Main 4
Jinan 4
Leawood 4
Macerata 4
Norwalk 4
Verona 4
Zhengzhou 4
Baronissi 3
Bologna 3
Brasov 3
Chengdu 3
Detroit 3
Edinburgh 3
Guangzhou 3
Ningbo 3
Querétaro City 3
Reggio Emilia 3
San Francisco 3
Santa Clara 3
Springfield 3
Tokyo 3
Trieste 3
Ancona 2
Ankara 2
Barnet 2
Bentivoglio 2
Berlin 2
Cagliari 2
Cassino 2
Catania 2
Totale 2.235
Nome #
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 294
Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases 155
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 135
13C-octanoic acid breath test to study gastric emptying time 129
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 121
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 116
Irritable bowel syndrome and nickel allergy: What is the role of the low nickel diet? 109
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 97
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 97
Erratum to: Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study (Scientific Reports, (2018), 8, 1, (12624), 10.1038/s41598-018-29311-y) 95
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 94
Gastrointestinal motility disorder assessment in systemic sclerosis 94
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 92
Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome 92
Origin of celiac disease: How old are predisposing haplotypes? 89
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 86
Role of yeasts in healthy and impaired gut microbiota: the gut mycome 86
Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study 84
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? 83
Gastrointestinal motility disorder assessment in systemic sclerosis 78
Pancreatic function assessment 78
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 77
Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic 71
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease 69
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 66
Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome 64
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 64
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study 59
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy 57
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 54
SECRETOME MODULATION OF CACO2 CELL LINE INDUCED BY A MULTI-STRAIN PROBIOTIC 53
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 53
Diet-Induced Alterations in Gut Microbiota Composition and Function 53
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE 49
Evaluation of tolerability and major factors affecting the adherence to probiotic therapy in patients with irritable bowel syndrome: a prospective, observational, real-life study 47
Gut and reproductive tract microbiota adaptation during pregnancy: New insights for pregnancy-related complications and therapy 46
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 43
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 41
Gut microbiota during dietary restrictions: New insights in non-communicable diseases 39
The Microbiota-Gut-Brain Axis: Psychoneuroimmunological Insights 36
Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pilot study 34
Bariatric procedures and microbiota: patient selection and outcome prediction 34
Radiomics could predict surgery at 10 years in Crohn's disease 33
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis 33
Onset of ulcerative colitis after thyrotoxicosis: a case report and review of the literature 31
Risk factors for gastric cancer: is it time to discard PPIs? 31
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 27
Popular diets and nutritional assessment in the management of irritable bowel syndrome in inflammatory bowel disease: an overview of current evidence 27
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 22
Gut and reproductive tract microbiota adaptation during pregnancy: New insights for pregnancy-related complications and therapy 21
The Microbiota-Gut-Brain Axis: Psychoneuroimmunological Insights 20
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 19
Cytomegalovirus Infection: An Underrated Target in Inflammatory Bowel Disease Treatment 18
Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together 17
Extracellular Vesicles: Novel Potential Therapeutic Agents in Inflammatory Bowel Diseases 17
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease 17
1L- vs. 4L-Polyethylene glycol for bowel preparation before colonoscopy among inpatients: A propensity score-matching analysis 17
Clinical value of alarm features for colorectal cancer: A meta-analysis 16
Clinical value of alarm features for colorectal cancer: A meta-analysis 14
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study 14
Factors That Affect Adequacy of Colon Cleansing for Colonoscopy in Hospitalized Patients 14
Systematic review with meta-analysis: the appropriateness of colonoscopy increases the probability of relevant findings and cancer while reducing unnecessary exams 12
How to identify patients who are less likely to have metachronous neoplasms after a colon cancer: A predictive model 10
The diagnostic yield of colonoscopy in hospitalized patients. An observational multicenter prospective study 10
Systematic review with meta-analysis: the appropriateness of colonoscopy increases the probability of relevant findings and cancer while reducing unnecessary exams 9
The diagnostic yield of colonoscopy in hospitalized patients. An observational multicenter prospective study 9
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission 9
Factors That Affect Adequacy of Colon Cleansing for Colonoscopy in Hospitalized Patients 8
1L- vs. 4L-Polyethylene glycol for bowel preparation before colonoscopy among inpatients: A propensity score-matching analysis 7
Higher adenoma recurrence rate after left- versus right-sided colectomy for colon cancer 4
Totale 3.899
Categoria #
all - tutte 19.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.375


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020275 0 0 0 0 30 33 51 10 26 29 74 22
2020/2021281 14 30 6 26 39 17 32 6 30 16 57 8
2021/2022364 15 25 5 14 22 16 6 71 14 51 56 69
2022/2023930 108 126 79 136 58 101 55 79 93 36 40 19
2023/2024728 25 125 51 46 42 108 50 19 46 34 82 100
2024/2025369 27 42 147 52 101 0 0 0 0 0 0 0
Totale 3.899